Data / Form D filings / Strella Biotechnology, Inc.
Strella Biotechnology, Inc.: Form D filings
Strella Biotechnology, Inc., a biotechnology company in Seattle, WA, filed 3 Form D notices with the SEC between 2020 and 2026. The latest, on August 14, 2026, reports $1.8 million sold of a $3.3 million offering to 35 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1601 2nd Ave, STE 575, Seattle, WA, 98101
- Phone
- (703) 909-4543
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1810011
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | New notice | $3,250,000 | $1,761,591 | $1,488,409 | 35 | Jun 29, 2026 | sec.gov |
| Sep 10, 2024 | New notice | $5,602,000 | $5,602,000 | 17 | Feb 21, 2024 | sec.gov | |
| Apr 17, 2020 | New notice | $3,316,213 | $3,316,213 | 17 | Apr 2, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Katherine Sizov | Executive Officer, Director, Promoter |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Automera US Inc. $1 million · Aug 7, 2026
Every Form D from the week of Aug 10, 2026 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Strella Biotechnology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.